Company intelligence / Profile preview

Biovault

Plymouth, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Biovault is a UK-accredited, commercial human tissue and cell bank providing processing, storage, and release for stem cells, cord blood, and tissue products; has supported over 4000 transplant cases in collaboration with the NHS and globally

Therapeutic areas: HematologyOtherImmunology
Modalities: Cell therapyStem cell therapyTissue allograftPeripheral blood stem cell storageCord blood and tissue banking
Industry: Contract Manufacturing Organization

Partnerships

National Health Service (NHS; UK)

Beyond the preview

Go deeper on Biovault.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biovault.

Explore the full profile